Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.0380
0.00 (0.00%)
Jul 23, 2026, 9:30 AM EST
Bio-Path Holdings Market Cap
Bio-Path Holdings has a market cap or net worth of $1.91 million as of July 23, 2026. Its market cap has increased by 48.42% in one year.
Market Cap
1.91M
Enterprise Value
2.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
ChartMarket Cap Chart
Since February 15, 2008, Bio-Path Holdings's market cap has decreased from 31.22M to 1.91M, a decrease of -93.88%. That is a compound annual growth rate of -14.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 1.91M | 244.67% |
| Dec 31, 2025 | 554.53K | -88.90% |
| Dec 31, 2024 | 5.00M | -12.65% |
| Dec 29, 2023 | 5.72M | -52.42% |
| Dec 30, 2022 | 12.02M | -55.47% |
| Dec 31, 2021 | 26.99M | 69.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioxytran | 2.78M |
| CASI Pharmaceuticals | 2.78M |
| ProtoKinetix | 2.63M |
| Biomind Labs | 2.60M |
| VitaSpring Biomedical | 2.30M |
| America Great Health | 2.12M |
| Iterum Therapeutics | 1.64M |
| Hepion Pharmaceuticals | 1.56M |